The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing.
from Food and Drug Administration--Press Releases http://ift.tt/2yOaxUQ
via IFTTT
No comments:
Post a Comment